IP Library Granted Patent US 9,580,414
Granted Patent B2
US 9,580,414 · App. 14/415,995 · Granted Feb 28, 2017

Salts and hydrates of antipsychotics

Inventors: Vijayabaskar Veerappan (Chennai, IN); Srimurugan Sankareswaran (Chennai, IN); Sathish Kumar Raman Viswanathan (Chennai, IN); N. Subramanian (Chennai, IN)
Assignee: Shasun Pharmaceuticals Limited
C07D417/14C07D417/12C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,580,414
App. No.
14/415,995
Granted
Feb 28, 2017
Kind
B2
Abstract

The present invention relates to a novel salt of (3aR,4S,7R,7aS)-2-[((1R,2R)-2-{[4-(1,2-benzisothiazol-3-yl)-piperazin-1-yl]methyl}cyclohexyl)methyl]hexahydro-1H-4,7-methanisoindol-1,3-dione and hydrates thereof, to methods for preparing the novel salt and its hydrates. In one aspect, the present invention provides a compound which is lurasidone dihydrochloride. In another aspect, the present invention provides a process for preparation of lurasidone dihydrochloride comprising: (i) mixing lurasidone free base in an organic solvent system; (ii) subjecting step (i) mixture to acid proton source; and (iii) isolating compound of lurasidone dihydrochloride.

Claims (5)

1. A compound of Formula-I

2. The compound according to claim 1 , wherein said compound is crystalline.

3. The compound according to claim 1 , wherein said compound is a hydrate.

4. The compound of claim 3 , wherein said hydrate is dihydrate.

5. The compound according to claim 4 having an X-ray diffraction pattern comprising peaks at 4.4±0.2, 12.6±0.2, 13.9±0.2, 26.2±0.2, 20.9±0.2 and 17.2±0.2 degrees 2θ.

Assignments (4)
CHANGE OF NAME Recorded Jan 27, 2017
From: SHASUN CHEMICALS & DRUGS LTD.
To: SHASUN PHARMACEUTICALS LIMITED
Reel/Frame 041107/0960 →
CORRECTIVE ASSIGNMENT TO DELETE THE FIRST ASSIGNOR'S DATA PREVIOUSLY RECORDED ON REEL 036725 FRAME 0897. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT DOCUMENT. Recorded Jan 25, 2017
From: SANKARESWARAN, SRIMURUGAN; VISWANATHAN, SATHISH KUMAR RAMAN; SUBRAMANIAN, N.
To: SHASUN PHARMACEUTICALS LIMITED
Reel/Frame 041482/0989 →
EMPLOYMENT AGREEMENT Recorded Nov 15, 2016
From: VEERAPPAN, VIJAYABASKAR
To: SHASUN CHEMICALS & DRUGS LTD.
Reel/Frame 041113/0790 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2015
From: VEERAPPAN, VIJAYABASKAR; SANKARESWARAN, SRIMURUGAN; VISWANATHAN, SATHISH KUMAR RAMAN; SUBRAMANIAM, N.
To: SHASUN PHARMACEUTICALS LIMITED
Reel/Frame 036725/0897 →
Priority Claims (1)
IN 2896/CHE/2012 · Jul 18, 2012 · national
Continuity (1)
Related Publication 20150175596A1 · Jun 25, 2015